Retrospective evaluation of revised criteria for the diagnosis of Alzheimer's disease using a cohort with post-mortem diagnosis

被引:29
作者
de Jager, Celeste A. [1 ]
Honey, Thurza E. M. [1 ]
Birks, Jacqueline [2 ]
Wilcock, Gordon K. [3 ]
机构
[1] Univ Oxford, Oxford Project Investigate Memory & Ageing OPTIMA, Dept Physiol Anat & Genet, Oxford OX1 2JD, England
[2] Univ Oxford, Ctr Stat Med, Oxford OX1 2JD, England
[3] Univ Oxford, Nuffield Dept Med & Biomed Res Ctr, Oxford OX1 2JD, England
关键词
autopsy confirmation; Alzheimer's disease; diagnosis; diagnosis of Alzheimer's disease; post-mortem; pre-dementia; MILD COGNITIVE IMPAIRMENT; PHOSPHORYLATED TAU; CLINICAL-DIAGNOSIS; CSF BIOMARKERS; DEMENTIA; ACCURACY; RELIABILITY; CERAD;
D O I
10.1002/gps.2448
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Objective: The criteria currently used to diagnose Alzheimer's disease (AD) require the presence of dementia, i.e. cognitive impairment sufficient to affect normal social and/or occupational function. Dubois et al. (Dubois et al., 2007) have recently proposed a set of revised criteria that may aid the diagnosis of the earlier stages of AD, and do not require the presence of dementia. We aimed to evaluate the new predementia-AD criteria through their retrospective application to the OPTIMA cohort with post-mortem (PM) confirmed diagnoses. Methods: The criteria were evaluated for sensitivity and specificity using cognitive, neuroimaging and cerebrospinal fluid data and clinical information for exclusion criteria. Limitations in choice of cognitive test, use of CT scans rather than M RI and missing CSFs affected the outcomes. Analyses were carried out for the whole cohort (n = 243) and on a mild-stage subgroup (n = 99) defined by MMSE >= 21. Results: Of the four options for fulfilling the revised-criteria, the best results for the whole cohort were achieved using memory and CSF data with exclusion criteria applied (.68 sensitivity and .93 specificity). The pattern was similar for the mild cohort, but with lower sensitivity. Specificities of 1.0 were reached with supportive criteria, CSF and CST plus MTL. Conclusions: The revised-criteria, when applied to our cohort, offer good specificity and reasonable sensitivity when compared with the gold standard of PM diagnosis. The criteria were not more effective for early stage dementia. Copyright 2010 John Wiley & Sons, Ltd.
引用
收藏
页码:988 / 997
页数:10
相关论文
共 22 条
  • [1] RELIABILITY OF THE WASHINGTON-UNIVERSITY CLINICAL DEMENTIA RATING
    BURKE, WJ
    MILLER, JP
    RUBIN, EH
    MORRIS, JC
    COBEN, LA
    DUCHEK, J
    WITTELS, IG
    BERG, L
    [J]. ARCHIVES OF NEUROLOGY, 1988, 45 (01) : 31 - 32
  • [2] Diagnosis of early dementia by the Double Memory Test: Encoding specificity improves diagnostic sensitivity and specificity
    Buschke, H
    Sliwinski, MJ
    Kuslansky, G
    Lipton, RB
    [J]. NEUROLOGY, 1997, 48 (04) : 989 - 997
  • [3] Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment
    DeCarli, C
    [J]. LANCET NEUROLOGY, 2003, 2 (01) : 15 - 21
  • [4] Research criteria for the diagnosis of Alzheimer"s disease: revising the NINCDS-ADRDA criteria
    Dubois, Bruno
    Feldman, Howard H.
    Jacova, Claudia
    Dekosky, Steven T.
    Barberger-Gateau, Pascale
    Cummings, Jeffrey
    Delocourte, Andre
    Galasko, Douglas
    Gauthier, Serge
    Jicha, Gregory
    Meguro, Kenichi
    O'Brien, John
    Pasquier, Florence
    Robert, Philippe
    Rossor, Martin
    Solloway, Steven
    Stern, Yaakov
    Visser, Pieter J.
    Scheltens, Philip
    [J]. LANCET NEUROLOGY, 2007, 6 (08) : 734 - 746
  • [5] Diagnosing dementia: Interrater reliability assessment and accuracy of the NINCDS/ADRDA criteria versus CERAD histopathological criteria for Alzheimer's disease
    Hogervorst, E
    Barnetson, L
    Jobst, KA
    Nagy, Z
    Combrinck, M
    Smith, AD
    [J]. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (02) : 107 - 113
  • [6] JOBST KA, 1992, LANCET, V340, P1179
  • [7] Hippocampal volumes in Alzheimer's disease, Parkinson's disease with and without dementia, and in vascular dementia: An MRI study
    Laakso, MP
    Partanen, K
    Riekkinen, P
    Lehtovirta, M
    Helkala, EL
    Hallikainen, M
    Hanninen, T
    Vainio, P
    Soininen, H
    [J]. NEUROLOGY, 1996, 46 (03) : 678 - 681
  • [8] Biochemical diagnosis of Alzheimer disease by measuring the cerebrospinal fluid ratio of phosphorylated tau protein to β-amyloid peptide42
    Maddalena, A
    Papassotiropoulos, A
    Müller-Tillmanns, B
    Jung, HH
    Hegi, T
    Nitsch, RM
    Hock, C
    [J]. ARCHIVES OF NEUROLOGY, 2003, 60 (09) : 1202 - 1206
  • [9] Marcos Alberto, 2006, Am J Alzheimers Dis Other Demen, V21, P189, DOI 10.1177/1533317506289348
  • [10] CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
    Mattsson, Niklas
    Zetterberg, Henrik
    Hansson, Oskar
    Andreasen, Niels
    Parnetti, Lucilla
    Jonsson, Michael
    Herukka, Sanna-Kaisa
    van der Flier, Wiesje M.
    Blankenstein, Marinus A.
    Ewers, Michael
    Rich, Kenneth
    Kaiser, Elmar
    Verbeek, Marcel
    Tsolaki, Magda
    Mulugeta, Ezra
    Rosen, Erik
    Aarsland, Dag
    Visser, Pieter Jelle
    Schroeder, Johannes
    Marcusson, Jan
    de Leon, Mony
    Hampel, Harald
    Scheltens, Philip
    Pirttilae, Tuula
    Wallin, Anders
    Jonhagen, Maria Eriksdotter
    Minthon, Lennart
    Winblad, Bengt
    Blennow, Kaj
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2009, 302 (04): : 385 - 393